[Basic therapy of chronic heart failure with digitalis or diuretics?]

Area of Science:

• Cardiology
• Pharmacology

Background:

• Chronic heart failure (CHF) management remains a clinical challenge.
• Current treatments aim to improve symptoms and reduce mortality.
• Understanding the comparative efficacy of different drug classes is crucial.

Purpose of the Study:

• To compare the efficacy of a diuretic combination (hydrochlorothiazide + triamterene) versus a digitalis glycoside in patients with heart failure and sinus rhythm.
• To evaluate the impact of these treatments on clinical symptoms and objective hemodynamic parameters.

Main Methods:

• A randomized crossover study involving 16 patients with heart failure and sinus rhythm.
• Patients received either a diuretic combination or a digitalis glycoside for 4-6 weeks, followed by a crossover to the other treatment after a washout period.
• Hemodynamic measurements including pulmonary wedge pressure and cardiac output were assessed at rest and during exercise.

Main Results:

• Diuretic treatment significantly lowered pulmonary arterial pressure, pulmonary wedge pressure, and pulmonary artery pressure during exercise compared to no treatment.
• Digitalis glycosides showed a modest, non-significant improvement in objective measures and symptoms in a subset of patients.
• Diuretics improved symptoms in five patients and led to slight reductions in heart size and ventricular volume.

Conclusions:

• Diuretics demonstrate significant hemodynamic benefits in managing chronic heart failure, particularly in reducing pulmonary pressures.
• The findings support the primary use of diuretics in the treatment of chronic heart failure.
• Further research may explore optimal diuretic strategies in heart failure management.